Skip to main content

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments:



You can also read the NHS Guide to Care.Data, Information on Care.Data on NHS Choices, and an Unofficial Guide to Care.Data published by wired.co.uk.

Comments

Anonymous said…
Don't forget the constant failure of Government inspired databases
9:08 pm
cobweb said…
remember if you wish to agree to share there may be others in your life who may not wish to agree so you will be compromising their right to privacy
5:49 pm
Anonymous said…
"Don't forget the constant failure of Government inspired databases" <-- this database has been working fine for 25 years with secondary care data. All they're doing is expanding it to include primary care
2:03 am
boneman said…
I would say the 'Against' argument wins convincingly - on the basis of the two PowerPoint presentations...
1:48 pm
Anonymous said…
So sad to see so many against this excellent initiative. I would share my data willingly. Not just for my sake but for all mankind. Enormous benefits can come when all this data is "mined" by PhD students which can lead to better insights into some diseases and better treatments which benefit millions of people. Some comments elsewhere seem to be paranoid about private companies benefiting in some way. Every time you go to the chemist with a prescription it doesn't seem to bother you then. So the "Big Pharma" guys seem to be not so bad after all, when you need them.
8:32 am
Anonymous said…
There are a number of issues involved in care.data - including management of the linked datasets (which will be so rich that they ought to be considered re-identifiable): who has access and how that access is managed ( a 'data lab' environment such as the one operated by QResearch is inherently less risky than a release of the whole dataset): the quality of the data gathered, and whether the two (or more) datasets being linked contain comperable data.
see
http://phcsg.org/clicsig-5614-can-care-data-be-made-compatible-with-patient-confidentiality/
There has been support for the concept of using the incredibly rich data held in GP medical records for research purposes for a long time - hence the existence of research databases such as QResearch, the CPRD, ResearchOne, and THIN.
http://phcsg.org/publications/fair-shares-for-all-final/
2:28 pm
Post a Comment

Popular posts from this blog

Protecting Against the "Quad-demic": Influenza, Covid-19, Norovirus and RSV

As the NHS braces for a challenging winter season, it is grappling with a "quad-demic" of health emergencies caused by influenza, Covid-19, norovirus, and respiratory syncytial virus (RSV). This confluence of viral threats poses a significant risk to public health in the UK as well as putting strain on healthcare resources, emphasising the importance of preventive measures to safeguard public health. Public health measures such a vaccination and good personal hygiene are pivotal in reducing the impact of these illnesses, particularly for vulnerable groups. The Four Viruses: What Are They? Influenza: A highly contagious respiratory infection that causes significant illness each winter. It can lead to severe complications, particularly in the elderly, young children, pregnant women, and those with chronic health conditions. Covid-19: Though its most acute phase has passed, Covid-19 remains a concern, especially as new variants of SA...
Post a Comment
Read more

How can we work successfully across the health and care system to make a success of Pharmacy First?

Pharmacies in England to begin treating patients for seven common conditions. How can we work successfully across the health and care system to make a success of Pharmacy First? 1. The Pharmacy First scheme aims to provide convenient access to healthcare through community pharmacies. Patients with minor ailments or common conditions can seek advice and treatment directly from their local pharmacy instead of visiting a general practice, urgent care centre or emergency department. The conditions covered by the scheme may vary depending on local funding arrangements and participation of pharmacies.  2, A potential problem with Pharmacy First is pharmacists misdiagnosing a patient's condition. It may also lead to delays in patients seeing doctors when medical assessment is needed. To mitigate these risks, appropriate safeguards and referral pathways should be established, ensuring timely medical assessment when necessary. The scheme will also increase the workload of pharmacies, thereb...
Post a Comment
Read more